Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Duplessis

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
IEEE Transactions on Bio-Medical Engineering|December 23, 2021
Wearables Detect Malaria Early in a Controlled Human-Infection StudySidhartha Chaudhury, Chenggang Yu, Ruifeng Liu, et al.
Vaccine|September 4, 2023
GMP manufacture of Shigella flexneri 2a Artificial Invaplex (Invaplex<sub>AR</sub>) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteersChristopher Duplessis, Kristen A Clarkson, K Ross Turbyfill, et al.
Malaria Journal|December 18, 2013
A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugsNeils B Quashie, Nancy O Duah, Benjamin Abuaku, et al.
NPJ Vaccines|March 15, 2024
Author Correction: Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV-workshop reportMilton Maciel, Rama R Amara, Katharine J Bar, et al.
NPJ Vaccines|February 21, 2024
Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV-workshop reportMilton Maciel, Rama R Amara, Katharine J Bar, et al.
Clinical and Vaccine Immunology : CVI|September 2, 2016
Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I StudyMark S Riddle, Robert W Kaminski, Claudio Di Paolo, et al.
Vaccine|March 5, 2011
Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adultsNancy F Crum-Cianflone, Erik Iverson, Gabriel Defang, et al.
Influenza and Other Respiratory Viruses|May 31, 2016
Sentinel surveillance for influenza among severe acute respiratory infection and acute febrile illness inpatients at three hospitals in GhanaAlexander H Jones, William Ampofo, Richard Akuffo, et al.
Vaccine|August 22, 2021
Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coliTida Lee, Ramiro L Gutiérrez, Milton Maciel, et al.
Malaria Journal|November 1, 2013
Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policyNancy O Duah, Sena A Matrevi, Dziedzom K de Souza, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
IEEE Transactions on Bio-Medical Engineering|December 23, 2021
Wearables Detect Malaria Early in a Controlled Human-Infection StudySidhartha Chaudhury, Chenggang Yu, Ruifeng Liu, et al.
Vaccine|September 4, 2023
GMP manufacture of Shigella flexneri 2a Artificial Invaplex (Invaplex<sub>AR</sub>) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteersChristopher Duplessis, Kristen A Clarkson, K Ross Turbyfill, et al.
Malaria Journal|December 18, 2013
A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugsNeils B Quashie, Nancy O Duah, Benjamin Abuaku, et al.
NPJ Vaccines|March 15, 2024
Author Correction: Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV-workshop reportMilton Maciel, Rama R Amara, Katharine J Bar, et al.
NPJ Vaccines|February 21, 2024
Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV-workshop reportMilton Maciel, Rama R Amara, Katharine J Bar, et al.
Clinical and Vaccine Immunology : CVI|September 2, 2016
Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I StudyMark S Riddle, Robert W Kaminski, Claudio Di Paolo, et al.
Vaccine|March 5, 2011
Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adultsNancy F Crum-Cianflone, Erik Iverson, Gabriel Defang, et al.
Influenza and Other Respiratory Viruses|May 31, 2016
Sentinel surveillance for influenza among severe acute respiratory infection and acute febrile illness inpatients at three hospitals in GhanaAlexander H Jones, William Ampofo, Richard Akuffo, et al.
Vaccine|August 22, 2021
Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coliTida Lee, Ramiro L Gutiérrez, Milton Maciel, et al.
Malaria Journal|November 1, 2013
Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policyNancy O Duah, Sena A Matrevi, Dziedzom K de Souza, et al.
Pageof 3